2023 Form 5500 filing — Lupin Pharmaceuticals, Inc. 401(K) Profit Sharing Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015162726NAL0016877395001) for Lupin Pharmaceuticals, Inc. 401(K) Profit Sharing Plan, reported by Lupin Pharmaceuticals, Inc. under EIN 16-1674598 and plan number 001. It reports 772 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241015162726NAL0016877395001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Lupin Pharmaceuticals, Inc.
- EIN
- 16-1674598
- Plan number
- 001
- Location
- Naples, FL
- Participants
- 772
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $61,357,251
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $61,357,251
- Employer contributions
- $1,951,387
- Participant contributions
- $3,571,488
- Total income / additions
- $15,841,189
- Benefits paid
- $6,766,431
- Administrative expenses
- $13,290
- Total expenses
- $6,779,721
- Net increase / (decrease)
- $9,061,468
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Benefit Audit Group LLC | NONE | $7,550 | not reported in the loaded dataset |
| T Rowe Price Rps Inc | NONE | $5,740 | $0 |